MCGLYNN MARGARET G
SEC insider (Form 3/4/5 filer). CIK 0001215126. Director at NOVAVAX INC (NVAX) and 1 other issuer. 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 20, 2026. Located in GAITHERSBURG, MD.
Companies MCGLYNN MARGARET G has filed insider reports for
- NOVAVAX INC (NVAX): Director
- AMICUS THERAPEUTICS, INC. (FOLD): Director
MCGLYNN MARGARET G
CIK: 0001215126
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 20, 2026NVAX
NOVAVAX INC
ExerciseDirect18.9K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
14.2K shares- - Jun 18, 2026NVAX
NOVAVAX INC
AwardDirectStock Option (Right to Buy)
21.3K shares- - Apr 27, 2026FOLD
AMICUS THERAPEUTICS, INC.
DispositionDirect94.6K shares at avg. $14.50$1.4M - Jun 20, 2025NVAX
NOVAVAX INC
AwardDirectStock Option (Right to Buy)
28.3K shares at avg. $6.42- - Jun 20, 2025NVAX
NOVAVAX INC
AwardDirectRestricted Stock Units
18.9K shares- - Jun 12, 2025NVAX
NOVAVAX INC
ExerciseDirect10.4K shares- - Jun 5, 2025FOLD
AMICUS THERAPEUTICS, INC.
AwardDirect20.4K shares- - Dec 31, 2024NVAX
NOVAVAX INC
AwardDirect1.2K shares at avg. $8.61$10K - Sep 30, 2024NVAX
NOVAVAX INC
AwardDirect778 shares at avg. $12.77$10K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 20, 2026 |  NVAX NOVAVAX INC | Exercise | 18,880 | - | $0 | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Restricted Stock Units | 14,180 | - | - | Direct |
| Jun 18, 2026 | NVAX NOVAVAX INC | Award Stock Option (Right to Buy) | 21,270 | - | - | Direct |
| Apr 27, 2026 |  FOLD AMICUS THERAPEUTICS, INC. | Disposition | 94,631 | $14.50 | $1,372,150 | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award Stock Option (Right to Buy) | 28,326 | $6.42 | - | Direct |
| Jun 20, 2025 | NVAX NOVAVAX INC | Award Restricted Stock Units | 18,884 | - | - | Direct |
| Jun 12, 2025 | NVAX NOVAVAX INC | Exercise | 10,420 | - | - | Direct |
| Jun 5, 2025 | FOLD AMICUS THERAPEUTICS, INC. | Award | 20,414 | - | - | Direct |
| Dec 31, 2024 | NVAX NOVAVAX INC | Award | 1,178 | $8.61 | $10,143 | Direct |
| Sep 30, 2024 | NVAX NOVAVAX INC | Award | 778 | $12.77 | $9,935 | Direct |
1-10 of 12 transactions